Irvine, CA-based biotechnology company Aviir has secured $8m from Silicon Valley Bank
It includes $5m in growth debt capital and a $3m line of credit on receivables.
The company intends to use the proceeds to accelerate commercialization activities and infrastructure build-out for its cardiac risk assessment portfolio of laboratory tests targeted at fostering cardiac disease prevention.
Founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine, and led by Douglas Harrington, MD, CEO, Aviir focuses on discovery, development and commercialization of innovative cardiometabolic diagnostic tests.
FinSMEs
21/09/2012